A role for fosfomycin treatment in children for prevention of haemolytic–uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection
- 9 September 2015
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 46 (5), 586-589
- https://doi.org/10.1016/j.ijantimicag.2015.08.006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Risk Factors for the Hemolytic Uremic Syndrome in Children Infected With Escherichia coli O157:H7: A Multivariable AnalysisClinical Infectious Diseases, 2012
- Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, MinnesotaThe Pediatric Infectious Disease Journal, 2012
- Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 EnteritisJAMA, 2002
- Strain-Specific Differences in the Amount of Shiga Toxin Released from Enterohemorrhagic Escherichia coli O157 following Exposure to Subinhibitory Concentrations of Antimicrobial AgentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndromeEpidemiology and Infection, 1993
- Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritisThe Journal of Pediatrics, 1992
- Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observationsThe Journal of Pediatrics, 1990
- Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndromeThe Journal of Pediatrics, 1990
- Illnesses Associated withEscherichia coli0157:H7 InfectionsAnnals of Internal Medicine, 1988
- Hemorrhagic Colitis Associated with a RareEscherichia coliSerotypeThe New England Journal of Medicine, 1983